메뉴 건너뛰기




Volumn 14, Issue 3, 2012, Pages

Nothing lasts forever - a critical look at sustained remission

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

EID: 84860890300     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3795     Document Type: Editorial
Times cited : (5)

References (11)
  • 9
    • 67449124635 scopus 로고    scopus 로고
    • Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
    • Active-Controlled Study of Patients Receiving Infl iximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group
    • Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Aletaha D, Baker D, Han J, Bala M, St Clair; EW, . Active-Controlled Study of Patients Receiving Infl iximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis 2009, 68:823-827. Active-Controlled Study of Patients Receiving Infl iximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group.
    • (2009) Ann Rheum Dis , vol.68 , pp. 823-827
    • Smolen, J.S.1    Han, C.2    van der Heijde, D.M.3    Emery, P.4    Bathon, J.M.5    Keystone, E.6    Maini, R.N.7    Kalden, J.R.8    Aletaha, D.9    Baker, D.10    Han, J.11    Bala, M.12    St Clair13    , E.W.14
  • 10
    • 33750324355 scopus 로고    scopus 로고
    • Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes
    • Landewe R, van der HD, Klareskog L, van VR, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125.
    • (2006) Arthritis Rheum , vol.54 , pp. 3119-3125
    • Landewe, R.1    van der, H.D.2    Klareskog, L.3    van, V.R.4    Fatenejad, S.5
  • 11
    • 84859517375 scopus 로고    scopus 로고
    • Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
    • 3329225, 22121130
    • Smolen JS, Avila JC, Aletaha D. Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction. Ann Rheum Dis 2011, 71:687-693. 3329225, 22121130.
    • (2011) Ann Rheum Dis , vol.71 , pp. 687-693
    • Smolen, J.S.1    Avila, J.C.2    Aletaha, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.